tiprankstipranks
Trending News
More News >
Dr. Reddy's Laboratories Ltd (RDY)
NYSE:RDY
US Market
Advertisement

Dr Reddy's Laboratories (RDY) Financial Statements

Compare
435 Followers

Dr Reddy's Laboratories Financial Overview

Dr Reddy's Laboratories's market cap is currently $12.20B. The company's EPS TTM is $0.197; its P/E ratio is 18.26; and it has a dividend yield of 0.03%. Dr Reddy's Laboratories is scheduled to report earnings on July 23, 2025, and the estimated EPS forecast is $0.20. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 325.54B₹ 279.16B₹ 245.88B₹ 214.39B₹ 189.72B
Gross Profit₹ 190.43B₹ 163.61B₹ 202.97B₹ 113.84B₹ 103.08B
Operating Income₹ 71.84B₹ 67.73B₹ 96.28B₹ 40.82B₹ 36.06B
EBITDA₹ 96.67B₹ 88.42B₹ 74.43B₹ 47.74B₹ 45.71B
Net Income₹ 56.54B₹ 55.68B₹ 45.07B₹ 23.57B₹ 17.24B
Balance Sheet
Cash & Short-Term Investments₹ 57.91B₹ 81.47B₹ 66.75B₹ 44.37B₹ 34.57B
Total Assets₹ 492.99B₹ 387.52B₹ 322.85B₹ 296.65B₹ 265.49B
Total Debt₹ 46.77B₹ 20.02B₹ 13.47B₹ 33.84B₹ 30.31B
Net Debt₹ 32.11B₹ 12.91B₹ 7.69B₹ 18.99B₹ 15.48B
Total Liabilities₹ 155.82B₹ 106.97B₹ 89.99B₹ 106.13B₹ 90.51B
Stockholders' Equity₹ 333.39B₹ 280.55B₹ 232.86B₹ 190.53B₹ 174.98B
Cash Flow
Free Cash Flow₹ 12.03B₹ 18.00B₹ 40.01B₹ 9.06B₹ 23.14B
Operating Cash Flow₹ 46.43B₹ 45.43B₹ 58.87B₹ 28.11B₹ 35.70B
Investing Cash Flow₹ -58.08B₹ -40.28B₹ -41.37B₹ -26.39B₹ -22.66B
Financing Cash Flow₹ 18.91B₹ -3.76B₹ -26.86B₹ -2.42B₹ -298.00M
Currency in INR

Dr Reddy's Laboratories Earnings and Revenue History

Dr Reddy's Laboratories Debt to Assets

Dr Reddy's Laboratories Cash Flow

Dr Reddy's Laboratories Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis